CXT trades 23.1% below Wall Street's consensus target of $60.50.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CXT achieves its forward estimates and maintains a stable P/E multiple of 11.6x. This scenario reflects the blended consensus of 7 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 30, 2026, Crane NXT, Co. (CXT) has a Wall Street consensus price target of $60.50, based on estimates from 7 covering analysts. With the stock currently trading at $49.14, this represents a potential upside of +23.1%. The company has a market capitalization of $2.83B.
Analyst price targets range from a low of $52.00 to a high of $67.00, representing a 25% spread in expectations. The median target of $61.50 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 6 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, CXT trades at a trailing P/E of 19.7x and forward P/E of 11.6x. Analysts expect EPS to grow +89.2% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $57.75, with bear and bull scenarios of $36.39 and $76.10 respectively. Model confidence stands at 45/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
CIXCompX International Inc. | $324M | $26.29 | — | — | — | 97.4x | — |
VRNTVerint Systems Inc. | $1.2B | $20.51 | $32.57 | +58.8% | Hold | 7.0x | 16 |
OSISOSI Systems, Inc. | $3.5B | $213.24 | $310.00 | +45.4% | Buy | 20.5x | 18 |
GLOBGlobant S.A. | $1.3B | $30.08 | $54.56 | +81.4% | Buy | 4.8x | 29 |
DBDDiebold Nixdorf, Incorporated | $2.9B | $83.45 | $100.00 | +19.8% | Buy | 15.2x | 13 |
VVisa Inc. | $655.4B | $341.65 | $368.91 | +8.0% | Buy | 26.0x | 61 |
MAMastercard Incorporated | $451.1B | $509.64 | $660.43 | +29.6% | Buy | 25.9x | 64 |
FISFidelity National Information Services, Inc. | $20.0B | $38.69 | $62.88 | +62.5% | Buy | 6.2x | 37 |
FISVFiserv, Inc. | $26.1B | $48.83 | $71.15 | +45.7% | Buy | 6.0x | 60 |
BRBroadridge Financial Solutions, Inc. | $15.8B | $135.44 | $210.00 | +55.1% | Buy | 14.2x | 24 |
Quick answers to the most common questions about buying CXT stock.
The consensus Wall Street price target for CXT is $60.5, representing 23.1% upside from the current price of $49.14. With 7 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
CXT has a consensus rating of "Buy" based on 7 Wall Street analysts. The rating breakdown is predominantly bullish, with 6 Buy/Strong Buy ratings. The consensus 12-month price target of $60.5 implies 23.1% upside from current levels.
With a forward P/E of 11.6063x, CXT trades at a relatively low valuation. The consensus target of $60.5 implies 23.1% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $67 for CXT, while the most conservative target is $52. The consensus of $60.5 represents the median expectation. Our quantitative valuation model projects a bull case target of $76 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CXT is moderately covered, with 7 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 6 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CXT stock forecast based on 7 Wall Street analysts shows a consensus price target of $60.5, with estimates ranging from $52 (bear case) to $67 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $58, with bear/bull scenarios of $36/$76.
Our quantitative valuation model calculates CXT's fair value at $58 (base case), with a bear case of $36 and bull case of $76. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 45/100.
CXT trades at a forward P/E ratio of 11.6x based on next-twelve-months earnings estimates compared to a trailing P/E of 19.7x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on CXT, with a "Buy" consensus rating and $60.5 price target (23.1% upside). 6 of 7 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CXT analyst price targets range from $52 to $67, a 25% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $60.5 consensus represents the middle ground. Our model's $36-$76 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.